Clinical Trial Update: Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating long-term safety and tolerability of SAR339658 in patients with ulcerative colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SAR339658

Snippet

Sponsor: Sanofi | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED